Immune responses to duck hepatitis B virus infection

Developmental and Comparative Immunology

Volumn 24, Issue 2-3, 2000, Pages 285-302

  Jilbert, A R ^a,b   Kotlarski, I ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Anti DHBV antibodies; DNA vaccines; Duck hepatitis B virus infection; Immunoglobulins; Interferons

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN; VIRUS ANTIGEN;

ANIMAL DISEASE; CELLULAR IMMUNITY; CYTOPATHOGENIC EFFECT; DUCK; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VACCINATION; VETERINARY MEDICINE; VIRION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS REPLICATION;

ANAS SP.; ANIMALIA; AVES; DUCK HEPATITIS B VIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS B VIRUS;

EID: 0034162541     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(99)00079-8     Document Type: Article

References (95)

1. Chang S-F, Netter HJ, Bruns M, Schneider R, Frôlich K, Will H. A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA. Virology (in press).
2. Tuttleman J.S., Pugh J.C., Summers J.W. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol. 58:1986;17-25.
3. Jilbert A.R., Miller D.S., Scougall C.A., Turnbull H., Burrell C.J. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: One virus DNA genome is infectious in neonatal ducks. Virology. 226:1996;338-345.
4. Schödel F, Sprengel R, Weimer T, Fernholz D, Schneider R, Will H. Animal hepatitis B viruses. In: Klein G, editor. Adv Viral Oncol. 1989;8: 73-100.
5. Klingmüller U., Schaller H. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. Virology. 67:1993;7414-7422.
6. Schlicht H.J. Biosynthesis of the secretory core protein of duck hepatitis B virus: intracellular transport, proteolytic processing, and membrane expression of the precore protein. J. Virol. 65:1991;3489-3495.
7. Wang G.H., Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67:1993;6507-6512.
8. Netter H.J., Chassot S., Chang S.F., Cova L., Will H. Sequence heterogeneity of heron hepatitis B virus genomes determined by full-length DNA amplification and direct sequencing reveals novel and unique features. J. Gen. Virol. 78:1997;1707-1718.
9. Breiner K.M., Urban S., Schaller H. Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses. J. Virol. 72:1998;8098-8104.
10. Ganem D. Hepadnaviridae and their replication. Fields B.N., Knipe D.M., Howley P.M. Fundamental virology. 3rd ed. 1996;1199-1233 Lippincott-Raven, New York.
11. Nassal M., Schaller H. Hepatitis B virus replication - an update. J. Viral Hepatol. 3:1996;217-226.
12. Summers J.W., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29:1982;403-415.
13. Urban M.K., O'Connell A.P., London W.T. Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus. J. Virol. 55:1985;16-22.
14. Jilbert A.R., Wu T.-T., England J.M., Hall Pd.l.M, Carp N.Z., O'Connell A.P., Mason W.S. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1992;1377-1388.
15. Marion P.L., Knight S.S., Ho B.K., Guo Y.Y., Robinson W.S., Popper H. Liver disease associated with duck hepatitis B virus infection of domestic ducks. Proc. Natl. Acad. Sci. USA. 81:1984;898-902.
16. Cullen J.M., Marion P.L., Newbold J.E. A sequential histologic and immunohistochemical study of duck hepatitis B virus infection in Pekin ducks. Vet. Immunol. 26:1989;164-172.
17. Jilbert A.R., Freiman J.S., Burrell C.J., Holmes M., Gowans E.J., Rowland R., Hall PdlM, Cossart Y.E. Virus-liver cell interactions in duck hepatitis B virus infection: a study of virus dissemination within the liver. Gastroenterology. 95:1988;1372-1382.
18. Marion P.L., Cullen J.M., Azarraga R.R., Van Davelaar M.J., Robinson W.S. Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology. 7:1987;724-731.
19. Tagawa M., Omata M., Yokosuka O., Uchiumi K., Imazeki F., Okuda K. Early events in duck hepatitis B virus infection: Sequential appearance of viral deoxyriboneucleic acid in the liver, pancreas, kidney, and spleen. Gastroenterology. 89:1985;1224-1229.
20. Fukuda R., Fukumoto S., Shimada Y. A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus. J. Med. Virol. 21:1987;311-320.
21. Jilbert A.R., Botten J.A., Miller D.S., Bertram E.M., Hall Pd.l.M, Kotlarski I., Burrell C.J. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology. 243:1998;273-282.
22. Qiao M., Gowans E.J., Bailey S.E., Jilbert A.R., Burrell C.J. Serological analysis of duck hepatitis B virus infection. Virus Res. 17:1990;3-4.
23. Vickery K., Cossart Y.E. DHBV manipulation and prediction of the outcome of infection. J. Hepatol. 25:1996;504-509.
24. Niederau C., Heintges T., Lange S., Goldmann G., Niederau C.M., Mohr L., Houssinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. New Eng. J. Med. 334:1996;1422-1427.
25. Gerin J.L. Experimental WHV infection of woodchucks: an animal model of hepadnavirus-induced liver cancer. Gastroenterol. Jpn. Suppl. 2:1990;38-42.
26. Kajino K., Jilbert A.R., Saputelli J., Aldrich C.E., Cullen J., Mason W.S. Woodchuck hepatitis virus infections: very rapid recovery after prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:1994;5792-5803.
27. Zinkernagel R.M. Immunology taught by viruses. Science. 271:1996;173-178.
28. Sarzotti M., Robbins E.J. Hoffman P.M. Induction of protective CTL responses in newborn mice by murine retrovirus. Science. 271:1996;1726-1728.
29. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th-2 biased pattern that persists after adult boosting. Eur. J. Immunol. 26:1996;1489-1496.
30. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
31. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited: turning on newborn cells with dendritic cells. Science. 271:1996;1723-1726.
32. Cova L., Duflot A., Prave M., Trepo C. Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks. Arch. Virol. Suppl. 8:1993;81-87.
33. Duflot A., Mehrotra R., Yu S.Z., Barraud L., Trepo C., Cova L. Spectrum of liver disease and duck hepatitis B virus infection in a large series of Chinese ducks with hepatocellular carcinoma. Hepatology. 21:1995;1483-1491.
34. Imazeki F., Yaginuma K., Omata M., Okuda K., Kobayashi M., Koike K. Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma. J. Virol. 62:1988;861-865.
35. Cullen J.M., Marion P.L., Sherman G.J., Hong X., Newbold J.E. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free Pekin ducks. Cancer Res. 50:1990;4072-4080.
36. Guo J.T., Aldrich C.E., Mason W.S., Pugh J.C. Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck. Proc. Natl. Acad. Sci. USA. 93:1996;14548-14553.
37. Yang W., Summers J. Integration of hepadnaviral DNA in infected liver: evidence for a linear precursor. J. Virol. 73:1999.
38. Zimmerman B., Shalatin N., Grey H.M. Structural studies on the duck 5.7S and 7.8S immunoglobulins. Biochemistry. 10:1971;482-488.
39. Ng P.L.K., Higgins D.A. Bile immunoglobulin of the duck (Anas platyrhnchos). I Preliminary characterisation and ontogeny. Immunology. 58:1986;323-327.
40. Magor K.E., Warr G.W., Bando Y., Middleton D.L., Higgins D.A. Secretory immune system of the duck (Anas platyrhnchos). Identification and expression of the genes encoding IgA and IgM heavy chains. Eur. J. Immunol. 28:1998;1063-1068.
41. Hädge D., Ambrosius H. Radioimmunochemical studies on 7.8 S and 5.7 S duck immunoglobulins in comparison with Fab and Fc fragments of chicken IgY. Dev. Com. Immunol. 8:1984;131-139.
42. Higgins D.A., Warr G.W. Duck immunoglobulins: structure, functions and molecular genetics. Avian Path. 22:1993;211-236.
43. Benedict A.A., Pollard L. The ontogeny and structure of sea turtle immunoglobulins. Solomon J.B., Horton J.D. Developmental immunobiology. 1977;315-331 Elsevier, Amsterdam.
44. Magor K.E., Higgins D.A., Middleton D.L., Warr G.W. One gene encodes the heavy chains for three different forms of IgY in the duck. J. Immunol. 153:1994;5549-5555.
45. Hollinger F.B. Hepatitis B virus. Fields B.N., Knipe D.M. Virology. 2nd ed. 1990;2171-2236 Raven Press, New York.
46. Halpern M.S., Mason W.S., Coates L., O'Connell A.P., England J.M. Humoral immune responsiveness in duck hepatitis B virus-infected ducks. J. Virol. 61:1987;916-920.
47. Vickery K., Freiman J.S., Dixon R.J., Kearney R., Murray S., Cossart Y.E. Immunity in Pekin ducks experimentally and naturally infected with duck hepatitis B virus. J. Med. Virol. 28:1989;231-236.
48. Triyatni M., Jilbert A.R., Qiao M., Miller D.S., Burrell C.J. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72:1998;84-94.
49. Pugh J.C., Di Q., Mason W.S., Simmons H. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J. Virol. 69:1995;4814-4822.
50. Cheung R.C., Trujillo D.E., Robinson W.S., Greenberg H.B., Marion P.L. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks. Virology. 176:1990;546-552.
51. Cheung R.C., Robinson W.S., Marion P.L., Greenberg H.B. Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. J. Virol. 63:1989;2445-2451.
52. Lambert V., Fernholz D., Sprengel R., Fourel I., Deleage G., Wildner G., Peyret C., Trepo C., Cova L., Will H. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein. J. Virol. 64:1990;1290-1297.
53. Yuasa S., Cheung R.C., Pham Q., Robinson W.S., Marion P.L. Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Virology. 181:1991;14-21.
54. Chisari F.V., Ferrari C., Mondelli M.U. Hepatitis B virus structure and biology. Microb. Pathogen. 6:1989;311-325.
55. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:1995;29-60.
56. Ando K., Guidotti L.G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R.D., Schlicht H.J., Huang S.N., Chisari F.V. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:1994;3245-3253.
57. Ando K., Guidotti L.G., Wirth S., Ishikawa T., Schreiber R.D., Schlicht H.J., Huang S.N., Chisari F.V. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1993;1541-1554.
58. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
59. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M.-P., Rugiu F.S., Carli M., Ricci M., Romagnani S. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1and Th2 clones. J. Immunol. 148:1992;2142-2147.
60. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1992;1091-1098.
61. Lenchow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
62. Farrar M.F., Schreiber R.D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:1993;571-611.
63. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-γ Annu. Rev. Immunol. 15:1997;749-795.
64. Ziegler R.E., Joklik W.K. Effect of interferon on multiplication of avian sarcoma virus B77 in duck embryo fibroblasts. J. Interferon Cytokine Res. 1:1981;521-537.
65. Schultz U., Kock J., Schlicht H.-J., Staeheli P. Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. Virology. 212:1995;641-649.
66. Bertram E.M., Jilbert A.R., Kotlarski I. An homologous in vitro assay to detect lymphokines released by PHA-activated duck peripheral blood lymphocytes and spleen cells. Vet. Immunol. Immunopath. 56:1997;163-174.
67. Schultz U., Chisari F.V. Recombinant duck IFN-gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J. Virol. 73:1999;3162-3168.
68. Kaiser P., Wain H.M., Rothwell L. Structure of the chicken interferon-γ gene, and comparison to mammalian homologues. Gene. 207:1998;25-32.
69. Simmons J.R. Marshall A.J. Biology and comparative physiology of birds. 1996;358-361 Academic Press, New York.
70. Chen C.-L.H., Gâbel T.W.F., Kubota T., Cooper M.D. T cell development in the chicken. Poultry Sci. 73:1994;1012-1018.
71. Higgins D.A., Chung S.-K. Duck lymphocytes I. Purification and preliminary observations on surface markers. J. Immunol. Methods. 86:1986;231-238.
72. Higgins D.A., Teoh C.S.H. Duck lymphocytes II. Culture conditions for optimum transformation response to phytohaemagglutinin. J. Immunol. Methods. 106:1988;135-145.
73. Bertram E.M., Jilbert A.R., Kotlarski I. Optimization of an in vitro assay which measures the proliferation of duck T lymphocytes from peripheral blood in response to stimulation with PHA and ConA. Devel. Compar. Immunol. 21:1997;299-310.
74. Bertram E.M., Wilkinson R.G., Lee B.A., Jilbert A.R., Kotlarski I. Identification of duck T lymphocytes using anti-human T cell (CD3) antiserum. Vet. Immunol. Immunopath. 51:1996;353-363.
75. Mason D.Y., Cordell J., Brown M., Pallesen G., Ralfkiaer E., Rothbard J., Crumpton M., Gatter K.C. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J. Clin. Path. 42:1989;1194-1200.
76. Jones M., Cordell J., Beyers A.D., Tse A.G.D., Mason D.Y. Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J. Immunol. 150:1993;5429-5435.
77. Higgins D.A. Duck lymphocytes III. Transformation responses to some common mitogens. Comp. Immun. Microbiol. Infect. Dis. 13:1990;13-23.
78. Higgins D.A. Duck lymphocytes V. Transformation responses to phorbol ester and calcium ionophore. Comp. Biochem. Physiol. 101:1992;665-670.
79. Higgins D.A., Ko W.K.W. Duck lymphocytes VII. Selection of subpopulations using lectin-coated magnetic beads. Vet. Immunol. Immunopath. 44:1995;181-195.
80. Bertram E.M., Jilbert A.R., Kotlarski I. Characterization of duck thrombocytes. Research Vet. Sci. 64:1998;267-270.
81. Chan S.W.S., Bando Y., Warr G.W., Middleton D.L., Higgins D.A. Duck lymphocytes. VIII. T-lymphoblastoid cell lines from reticuloendotheliosis virus-induced tumours. Avian Path. 28:1999;171-186.
82. Reis S., Kaufer I., Reinacher M., Weiss E. Immunomorphic characterisation of chicken thrombocytes. Cell Tissue Res. 236:1984;1-3.
83. Traill K.N., Bock G., Boyd R., Wick G. Chicken thrombocytes. Isolation, serological and functional characterisation using the fluorescence activated cell sorter. Devel. Comp. Immunol. 7:1983;111-125.
84. Vickery K., Cossart Y., Gu X., Dixon R. Antigen-specific blastogenesis assays for duck hepatitis B virus using duck peripheral blood and splenic mononuclear cells. Vet. Immunol. Immunopath. 59:1997;349-358.
85. Vickery K., Cossart Y., Dixon R. The cellular immune response of ducks to duck hepatitis B virus infection. J. Med. Virol. 58:1999;19-25.
86. Vickery K., Cossart Y., Dixon R. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks. Vet. Microbiol. 68:1999;157-169.
87. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
88. Bot A., Bot S., Garcia-Sastre A., Bona C. DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Vir. Immunol. 9:1996;207-210.
89. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888.
90. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P.-H., Siegrist C.-A. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA. 94:1997;8726-8731.
91. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., Michel M.-L. DNA-mediated immunization breaks tolerance in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA. 93:1996;12496-12501.
92. Prince A.M., Whalen R., Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine. 15:1997;916-919.
93. Rollier C., Sunyach C., Barraud L., Mandani N., Jamard C., Trepo C., Cova L. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterol. 116:1999;658-665.
94. Lu M., Hilken G., Kruppenbacher J., Kemper T., Schirmbeck R., Reimann J., Roggendorf M. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J Virol. 73:1999;281-289.
95. Schödel F., Neckerman G., Peterson D., Fuchs K., Fuller S., Will H., Roggendorf M. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection. Vaccine. 11:1993;624-628.